$BRWC Balance Sheet | Understand Stock

$BRWC

$0.90 +$0.10 (12.5%) Close

Financial Statements

In USD, except per-share amounts

	Q4 FY2026 As of Jul 31, 2026	Q3 FY2026 As of Apr 30, 2026	Q2 FY2026 As of Jan 31, 2026	Q1 FY2026 As of Oct 31, 2025	Q4 FY2025 As of Jul 31, 2025	Q3 FY2025 As of Apr 30, 2025	Q2 FY2025 As of Jan 31, 2025	Q1 FY2025 As of Oct 31, 2024	Q4 FY2024 As of Jul 31, 2024	Q3 FY2024 As of Apr 30, 2024	Q2 FY2024 As of Jan 31, 2024	Q1 FY2024 As of Oct 31, 2023	Q4 FY2023 As of Jul 31, 2023	Q3 FY2023 As of Apr 30, 2023	Q2 FY2023 As of Jan 31, 2023	Q1 FY2023 As of Oct 31, 2022	Q4 FY2022 As of Jul 31, 2022	Q3 FY2022 As of Apr 30, 2022	Q2 FY2022 As of Jan 31, 2022	Q1 FY2022 As of Oct 31, 2021
ASSETS
Current assets
Cash and cash equivalents
Deferred costs
Accounts receivable
Prepayment
Prepayment (including $nil and $14,000 of prepayments to related party as of July 31, 2026 and July 31, 2025 respectively)
Total current assets

Non - current asset
Plant and equipment, net
Total non - current asset
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accrued liabilities
Amount due to a director
Director
Total amount due to a director
Amounts due to a director
Director
Total amounts due to a director

Amount owing to director
Total current liabilities

Total liabilities
Stockholders’ equity
Common stock – Par value $ 0.001; Authorized: 75,000,000 shares; Issued and outstanding: 6,720,000 shares as of July 31, 2026 and July 31, 2025, respectively
Additional paid in capital
Accumulated deficit
Total stockholders’ equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Comments